<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34440812</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>19</Day></DateCompleted><DateRevised><Year>2021</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4409</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>8</Issue><PubDate><Year>2021</Year><Month>Aug</Month><Day>10</Day></PubDate></JournalIssue><Title>Cells</Title><ISOAbbreviation>Cells</ISOAbbreviation></Journal><ArticleTitle>Circulating myomiRs in Muscle Denervation: From Surgical to ALS Pathological Condition.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2043</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/cells10082043</ELocationID><Abstract><AbstractText>ALS is a fatal neurodegenerative disease that is associated with muscle atrophy, motoneuron degeneration and denervation. Different mechanisms have been proposed to explain the pathogenesis of the disease; in this context, microRNAs have been described as biomarkers and potential pathogenetic factors for ALS. MyomiRs are microRNAs produced by skeletal muscle, and they play an important role in tissue homeostasis; moreover, they can be released in blood circulation in pathological conditions, including ALS. However, the functional role of myomiRs in muscle denervation has not yet been fully clarified. In this study, we analyze the levels of two myomiRs, namely miR-206 and miR-133a, in skeletal muscle and blood samples of denervated mice, and we demonstrate that surgical denervation reduces the expression of both miR-206 and miR-133a, while miR-206 but not miR-133a is upregulated during the re-innervation process. Furthermore, we quantify the levels of miR-206 and miR-133a in serum samples of two ALS mouse models, characterized by different disease velocities, and we demonstrate a different modulation of circulating myomiRs during ALS disease, according to the velocity of disease progression. Moreover, taking into account surgical and pathological denervation, we describe a different response to increasing amounts of circulating miR-206, suggesting a hormetic effect of miR-206 in relation to changes in neuromuscular communication.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Casola</LastName><ForeName>Irene</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, DAHFMO-Unit of Histology and Medical Embryology, Sapienza University of Rome, Via A. Scarpa, 14, 00161 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scicchitano</LastName><ForeName>Bianca Maria</ForeName><Initials>BM</Initials><Identifier Source="ORCID">0000-0002-9599-6642</Identifier><AffiliationInfo><Affiliation>Sezione di Istologia ed Embriologia, Dipartimento di Scienze della Vita e Sanit&#xe0; Pubblica, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Roma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lepore</LastName><ForeName>Elisa</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, DAHFMO-Unit of Histology and Medical Embryology, Sapienza University of Rome, Via A. Scarpa, 14, 00161 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mandillo</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-4869-0974</Identifier><AffiliationInfo><Affiliation>Institute of Biochemistry and Cell Biology, National Research Council, Monterotondo scalo, 00015 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Golini</LastName><ForeName>Elisabetta</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-9323-7124</Identifier><AffiliationInfo><Affiliation>Institute of Biochemistry and Cell Biology, National Research Council, Monterotondo scalo, 00015 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nicoletti</LastName><ForeName>Carmine</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-5896-2040</Identifier><AffiliationInfo><Affiliation>Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, DAHFMO-Unit of Histology and Medical Embryology, Sapienza University of Rome, Via A. Scarpa, 14, 00161 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barberi</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, DAHFMO-Unit of Histology and Medical Embryology, Sapienza University of Rome, Via A. Scarpa, 14, 00161 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dobrowolny</LastName><ForeName>Gabriella</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-8693-0724</Identifier><AffiliationInfo><Affiliation>Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, DAHFMO-Unit of Histology and Medical Embryology, Sapienza University of Rome, Via A. Scarpa, 14, 00161 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Musar&#xf2;</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-2944-9739</Identifier><AffiliationInfo><Affiliation>Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, DAHFMO-Unit of Histology and Medical Embryology, Sapienza University of Rome, Via A. Scarpa, 14, 00161 Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Scuola Superiore di Studi Avanzati Sapienza (SSAS), Sapienza University of Rome, 00185 Rome, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>08</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cells</MedlineTA><NlmUniqueID>101600052</NlmUniqueID><ISSNLinking>2073-4409</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C517732">Mirn133 microRNA, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C540669">Mirn206 microRNA, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="C000606291">Sod1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="N">MicroRNAs</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009121" MajorTopicYN="N">Muscle Denervation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018482" MajorTopicYN="N">Muscle, Skeletal</DescriptorName><QualifierName UI="Q000294" MajorTopicYN="N">innervation</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">circulating miRNA</Keyword><Keyword MajorTopicYN="N">muscle denervation</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>7</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>7</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>8</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>8</Month><Day>27</Day><Hour>1</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>8</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34440812</ArticleId><ArticleId IdType="pmc">PMC8393851</ArticleId><ArticleId IdType="doi">10.3390/cells10082043</ArticleId><ArticleId IdType="pii">cells10082043</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Musar&#xf2; A. Understanding ALS: New therapeutic approaches. FEBS J. 2013;280:4315&#x2013;4322. doi: 10.1111/febs.12087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.12087</ArticleId><ArticleId IdType="pubmed">23217177</ArticleId></ArticleIdList></Reference><Reference><Citation>McGoldrick P., Joyce P.I., Fisher E.M.C., Greensmith L. Rodent models of amyotrophic lateral sclerosis. Biochim. Biophys. Acta Mol. Basis Dis. 2013;1832:1421&#x2013;1436. doi: 10.1016/j.bbadis.2013.03.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2013.03.012</ArticleId><ArticleId IdType="pubmed">23524377</ArticleId></ArticleIdList></Reference><Reference><Citation>Acevedo-Arozena A., Kalmar B., Essa S., Ricketts T., Joyce P., Kent R., Rowe C., Parker A., Gray A., Hafezparast M., et al. A comprehensive assessment of the SOD1 G93A low-copy transgenic mouse, which models human amyotrophic lateral sclerosis. DMM Dis. Model. Mech. 2011;4:686&#x2013;700. doi: 10.1242/dmm.007237.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.007237</ArticleId><ArticleId IdType="pmc">PMC3180233</ArticleId><ArticleId IdType="pubmed">21540242</ArticleId></ArticleIdList></Reference><Reference><Citation>Horak M., Novak J., Bienertova-Vasku J. Muscle-specific microRNAs in skeletal muscle development. Dev. Biol. 2016;410:1&#x2013;13. doi: 10.1016/j.ydbio.2015.12.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ydbio.2015.12.013</ArticleId><ArticleId IdType="pubmed">26708096</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeng S.F., Rau C.S., Liliang P.C., Wu C.J., Lu T.H., Chen Y.C., Lin C.J., Hsieh C.H. Profiling muscle-specific microrna expression after peripheral denervation and reinnervation in a rat model. J. Neurotrauma. 2009;26:2345&#x2013;2353. doi: 10.1089/neu.2009.0960.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neu.2009.0960</ArticleId><ArticleId IdType="pubmed">19586368</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams A.H., Valdez G., Moresi V., Qi X., McAnally J., Elliott J.L., Bassel-Duby R., Sanes J.R., Olson E.N. MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science. 2009;326:1549&#x2013;1554. doi: 10.1126/science.1181046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1181046</ArticleId><ArticleId IdType="pmc">PMC2796560</ArticleId><ArticleId IdType="pubmed">20007902</ArticleId></ArticleIdList></Reference><Reference><Citation>Musar&#xf2; A., Dobrowolny G., Cambieri C., Onesti E., Ceccanti M., Frasca V., Pisano A., Cerbelli B., Lepore E., Ruffolo G., et al. Neuromuscular magnetic stimulation counteracts muscle decline in ALS patients: Results of a randomized, double-blind, controlled study. Sci. Rep. 2019;9:1&#x2013;14. doi: 10.1038/s41598-019-39313-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-39313-z</ArticleId><ArticleId IdType="pmc">PMC6391419</ArticleId><ArticleId IdType="pubmed">30808899</ArticleId></ArticleIdList></Reference><Reference><Citation>Cacchiarelli D., Martone J., Girardi E., Cesana M., Incitti T., Morlando M., Nicoletti C., Santini T., Sthandier O., Barberi L., et al. MicroRNAs involved in molecular circuitries relevant for the duchenne muscular dystrophy pathogenesis are controlled by the dystrophin/nNOS pathway. Cell Metab. 2010;12:341&#x2013;351. doi: 10.1016/j.cmet.2010.07.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2010.07.008</ArticleId><ArticleId IdType="pubmed">20727829</ArticleId></ArticleIdList></Reference><Reference><Citation>Toivonen J.M., Manzano R., Oliv&#xe1;n S., Zaragoza P., Garc&#xed;a-Redondo A., Osta R. MicroRNA-206: A potential circulating biomarker candidate for amyotrophic lateral sclerosis. PLoS ONE. 2014;9:e89065. doi: 10.1371/journal.pone.0089065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0089065</ArticleId><ArticleId IdType="pmc">PMC3930686</ArticleId><ArticleId IdType="pubmed">24586506</ArticleId></ArticleIdList></Reference><Reference><Citation>Khoury S., Tran N. Circulating microRNAs: Potential biomarkers for common malignancies. Biomark. Med. 2015;9:131&#x2013;151. doi: 10.2217/bmm.14.102.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/bmm.14.102</ArticleId><ArticleId IdType="pubmed">25689901</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobrowolny G., Martone J., Lepore E., Casola I., Petrucci A., Inghilleri M., Morlando M., Colantoni A., Scicchitano B.M., Calvo A., et al. A longitudinal study defined circulating microRNAs as reliable biomarkers for disease prognosis and progression in ALS human patients. Cell Death Discov. 2021;7:1&#x2013;11. doi: 10.1038/s41420-020-00397-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41420-020-00397-6</ArticleId><ArticleId IdType="pmc">PMC7801652</ArticleId><ArticleId IdType="pubmed">33431881</ArticleId></ArticleIdList></Reference><Reference><Citation>Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2&#x2212;&#x394;&#x394;CT method. Methods. 2001;25:402&#x2013;408. doi: 10.1006/meth.2001.1262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/meth.2001.1262</ArticleId><ArticleId IdType="pubmed">11846609</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruneteau G., Simonet T., Bauch&#xe9; S., Mandjee N., Malfatti E., Girard E., Tanguy M.L., Behin A., Khiami F., Sariali E., et al. Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: Potential role in reinnervation ability and disease progression. Brain. 2013;136:2359&#x2013;2368. doi: 10.1093/brain/awt164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awt164</ArticleId><ArticleId IdType="pubmed">23824486</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Pietro L., Lattanzi W., Bernardini C. Skeletal muscle microRNAs as key players in the pathogenesis of amyotrophic lateral sclerosis. Int. J. Mol. Sci. 2018;19:1534. doi: 10.3390/ijms19051534.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19051534</ArticleId><ArticleId IdType="pmc">PMC5983603</ArticleId><ArticleId IdType="pubmed">29786645</ArticleId></ArticleIdList></Reference><Reference><Citation>Raheja R., Regev K., Healy B.C., Mazzola M.A., Beynon V., Von Glehn F., Paul A., Diaz-Cruz C., Gholipour T., Glanz B.I., et al. Correlating serum micrornas and clinical parameters in amyotrophic lateral sclerosis. Muscle Nerve. 2018;58:261&#x2013;269. doi: 10.1002/mus.26106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.26106</ArticleId><ArticleId IdType="pmc">PMC6103911</ArticleId><ArticleId IdType="pubmed">29466830</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>